CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
COMPASS Pathways plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$11.11+0.36 (+3.35%)
Close on Oct 19, 2026
- Market cap
- $1.50B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$4.59 (+70.40%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $1.50B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 17.75
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$394.19M
- EPS, diluted
- -$4.60
- Book value per share
- $0.63
- Diluted shares
- 135M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Operating income
-$181.76M
Net income
-$394.19M
EPS, diluted
-$4.60
Free cash flow
–
Reported periodTrailing twelve months